Illinois Tool Works (ITW) Stake Has Raised by Bath Savings Trust Co; As Bioscrip (BIOS) Stock Price Declined, Holder Camber Capital Management Cut Position

May 27, 2018 - By Michael Collier

BioScrip, Inc. (NASDAQ:BIOS) Logo

Bath Savings Trust Co increased its stake in Illinois Tool Works Inc. (ITW) by 123.95% based on its latest 2017Q4 regulatory filing with the SEC. Bath Savings Trust Co bought 2,272 shares as the company’s stock declined 6.87% with the market. The institutional investor held 4,105 shares of the industrial machinery and components company at the end of 2017Q4, valued at $685,000, up from 1,833 at the end of the previous reported quarter. Bath Savings Trust Co who had been investing in Illinois Tool Works Inc. for a number of months, seems to be bullish on the $49.94B market cap company. The stock increased 0.05% or $0.07 during the last trading session, reaching $147.43. About 671,762 shares traded. Illinois Tool Works Inc. (NYSE:ITW) has risen 18.23% since May 27, 2017 and is uptrending. It has outperformed by 6.68% the S&P500.

Stephen Dubois decreased its stake in Bioscrip Inc (BIOS) by 59.68% based on its latest 2017Q4 regulatory filing with the SEC. Camber Capital Management Llc sold 3.76M shares as the company’s stock declined 10.25% with the market. The hedge fund run by Stephen Dubois held 2.54 million shares of the health care company at the end of 2017Q4, valued at $7.39 million, down from 6.30M at the end of the previous reported quarter. Camber Capital Management Llc who had been investing in Bioscrip Inc for a number of months, seems to be less bullish one the $321.16M market cap company. It closed at $2.51 lastly. It is down 42.70% since May 27, 2017 and is uptrending. It has outperformed by 31.15% the S&P500.

Among 19 analysts covering Illinois Tool Works Inc (NYSE:ITW), 8 have Buy rating, 0 Sell and 11 Hold. Therefore 42% are positive. Illinois Tool Works Inc had 90 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “In-Line” rating by Evercore given on Monday, August 7. The stock has “Buy” rating by Jefferies on Wednesday, April 12. Jefferies maintained Illinois Tool Works Inc. (NYSE:ITW) on Friday, October 20 with “Buy” rating. Goldman Sachs upgraded it to “Buy” rating and $155 target in Thursday, June 1 report. The firm earned “Hold” rating on Wednesday, January 24 by Robert W. Baird. Goldman Sachs upgraded Illinois Tool Works Inc. (NYSE:ITW) rating on Tuesday, April 10. Goldman Sachs has “Buy” rating and $17700 target. The firm earned “Market Perform” rating on Friday, May 4 by BMO Capital Markets. BMO Capital Markets maintained the shares of ITW in report on Tuesday, April 17 with “Hold” rating. The firm has “Buy” rating given on Monday, July 24 by Jefferies. On Thursday, April 21 the stock rating was maintained by Morgan Stanley with “Equal-Weight”.

More news for Illinois Tool Works Inc. (NYSE:ITW) were recently published by: Globenewswire.com, which released: “ITW Board of Directors Declares Quarterly Dividend” on May 04, 2018. Globenewswire.com‘s article titled: “ITW Announces Upcoming Investor Conferences” and published on May 07, 2018 is yet another important article.

Since December 8, 2017, it had 0 buys, and 2 selling transactions for $8.31 million activity. 30,000 shares were sold by SMITH HAROLD B, worth $4.99 million.

Investors sentiment increased to 0.9 in Q4 2017. Its up 0.03, from 0.87 in 2017Q3. It increased, as 39 investors sold ITW shares while 379 reduced holdings. 117 funds opened positions while 261 raised stakes. 229.09 million shares or 9.01% less from 251.79 million shares in 2017Q3 were reported. Arizona State Retirement Sys accumulated 92,441 shares. Thompson Siegel And Walmsley Ltd invested 0% of its portfolio in Illinois Tool Works Inc. (NYSE:ITW). The Indiana-based 1St Source Financial Bank has invested 0.02% in Illinois Tool Works Inc. (NYSE:ITW). Rothschild Investment Il invested in 0.42% or 23,406 shares. Meristem Limited Liability Partnership has 1,895 shares for 0.11% of their portfolio. Ingalls & Snyder Ltd Liability Com stated it has 11,885 shares. Gateway Advisers Limited Company holds 0.03% of its portfolio in Illinois Tool Works Inc. (NYSE:ITW) for 18,774 shares. Koch Indus Incorporated reported 0.24% in Illinois Tool Works Inc. (NYSE:ITW). 245,675 were accumulated by Dearborn Ptnrs Ltd Liability Corp. Somerset Trust Comm accumulated 16,590 shares or 1.38% of the stock. Acropolis Invest Limited Liability, Missouri-based fund reported 1,066 shares. Mutual Of America Capital Management Ltd Liability stated it has 0.1% of its portfolio in Illinois Tool Works Inc. (NYSE:ITW). Coho has 1.18 million shares for 4.87% of their portfolio. Denali Advsr Ltd Liability Corporation invested 1.86% of its portfolio in Illinois Tool Works Inc. (NYSE:ITW). Moreover, Optimum Advsr has 0.36% invested in Illinois Tool Works Inc. (NYSE:ITW).

Camber Capital Management Llc, which manages about $1.75B and $2.04B US Long portfolio, upped its stake in Tesaro Inc (NASDAQ:TSRO) by 450,000 shares to 850,000 shares, valued at $70.44 million in 2017Q4, according to the filing. It also increased its holding in Brookdale Senior Living (NYSE:BKD) by 1.10 million shares in the quarter, for a total of 6.50M shares, and has risen its stake in Clovis Oncology Inc (NASDAQ:CLVS).

Among 6 analysts covering BioScrip (NASDAQ:BIOS), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioScrip had 15 analyst reports since August 11, 2015 according to SRatingsIntel. Jefferies maintained the stock with “Buy” rating in Wednesday, August 9 report. Jefferies maintained the shares of BIOS in report on Thursday, June 8 with “Buy” rating. The firm earned “Buy” rating on Tuesday, January 3 by Lake Street. The firm has “Buy” rating given on Thursday, November 2 by SunTrust. The firm has “Buy” rating by SunTrust given on Tuesday, August 11. The firm has “Buy” rating by SunTrust given on Thursday, March 8. Jefferies maintained the shares of BIOS in report on Thursday, November 2 with “Buy” rating. Jefferies maintained it with “Buy” rating and $300 target in Tuesday, July 25 report. The stock has “Buy” rating by SunTrust on Wednesday, December 20. The rating was upgraded by SunTrust to “Buy” on Thursday, August 10.

Investors sentiment increased to 1.18 in Q4 2017. Its up 0.13, from 1.05 in 2017Q3. It is positive, as 12 investors sold BIOS shares while 28 reduced holdings. 19 funds opened positions while 28 raised stakes. 104.07 million shares or 0.29% less from 104.38 million shares in 2017Q3 were reported. Tiaa Cref Inv Mngmt Limited Liability Company holds 0% of its portfolio in BioScrip, Inc. (NASDAQ:BIOS) for 274,674 shares. Ameritas Investment Prns stated it has 0% of its portfolio in BioScrip, Inc. (NASDAQ:BIOS). Continental Ltd Liability Company invested 0.11% in BioScrip, Inc. (NASDAQ:BIOS). 1.11 million were accumulated by Geode Mgmt Limited Liability Company. Gabelli Funds Limited Liability Com has 0.17% invested in BioScrip, Inc. (NASDAQ:BIOS) for 10.36 million shares. 4.48 million are owned by D E Shaw & Inc. Moreover, Diamond Hill has 0.06% invested in BioScrip, Inc. (NASDAQ:BIOS). Legal General Group Plc holds 0% or 27,210 shares in its portfolio. 3.06 million were reported by Wynnefield Capital Incorporated. Goldman Sachs Group Inc Inc stated it has 41,842 shares or 0% of all its holdings. Blackrock reported 6.58M shares. Morgan Stanley holds 0% in BioScrip, Inc. (NASDAQ:BIOS) or 437,242 shares. Price T Rowe Associate Md holds 0% or 33,100 shares. Advisory Svcs Limited Company accumulated 14,800 shares or 0% of the stock. 111,291 were reported by Rhumbline Advisers.

More important recent BioScrip, Inc. (NASDAQ:BIOS) news were published by: Globenewswire.com which released: “Report: Developing Opportunities within Boston Private Financial, Ares Management, BioScrip, Glacier, CBIZ, and …” on May 03, 2018, also Globenewswire.com published article titled: “BioScrip Reports First Quarter 2018 Financial Results”, Globenewswire.com published: “BioScrip to Participate in Upcoming Investor Conferences” on May 16, 2018. More interesting news about BioScrip, Inc. (NASDAQ:BIOS) was released by: Seekingalpha.com and their article: “BioScrip (BIOS) Q1 2018 Results – Earnings Call Transcript” with publication date: May 10, 2018.

Analysts await BioScrip, Inc. (NASDAQ:BIOS) to report earnings on August, 14. They expect $-0.09 earnings per share, up 18.18% or $0.02 from last year’s $-0.11 per share. After $-0.12 actual earnings per share reported by BioScrip, Inc. for the previous quarter, Wall Street now forecasts -25.00% EPS growth.

Illinois Tool Works Inc. (NYSE:ITW) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: